Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baloxavir marboxil single-dose prophylaxis in household contacts of influenza patients (EU phase 3)
2020-000696-20Phase 3
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing Baloxavir marboxil prophylaxis with Placebo (2 arms).
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on 2020-000696-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000696-20.